EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

First-Trimester Universal One-Time Serology Screening for Cytomegalovirus: A Pilot Study at Two Tertiary Referral Centers in Barcelona (Catalunya, Spain)

Karen P Castillo, Laura Guirado, Alex Cahuana, María Angeles Marcos, Imma Mercadé, Elena Casals Font, Qiqi Liu, Clara Medina, Marta López, María Dolores Gómez-Roig, Francesc Figueras, Anna Goncé

Fetal Diagnosis and Therapy · 2025

DOI: 10.1159/000544169 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Fetal Diagnosis and Therapy, 2025. Verfasst von Karen P Castillo und 11 weiteren Autor:innen. Beteiligte Einrichtung: BCNatal Fetal Medicine Research Center, Hospital Clínic and Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain, karen.castillo.v@h…. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Pregnancy Trimester, First, Pregnancy Complications, Infectious, Cytomegalovirus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Congenital cytomegalovirus (cCMV) is the main infectious cause of sensorineural hearing loss and neurodevelopmental disability. First-trimester and periconceptional period are the most vulnerable times for fetal injury. Universal serological cytomegalovirus (CMV) screening in pregnant women is not currently recommended. After a recent randomized controlled clinical trial that demonstrated a 70% reduction of vertical transmission with high-dose valacyclovir (VCV), a pilot first-trimester screening program was launched at our setting.

Methods

This epidemiological surveillance study was conducted at two tertiary hospitals in Barcelona. The primary outcome was to evaluate the results of the first 2 years of implementation of a universal first-trimester CMV screening program. The secondary outcome was to assess maternal seroprevalence, and the burden of primary infection during the fetal risk period in this population. IgG and IgM antibodies were determined in first-trimester pregnant women at the time of the combined test for aneuploidy. In those with positive IgG and IgM, IgG avidity was performed through a fast alert system. Low or intermediate avidity was considered as primary infection in the first-trimester or periconceptional period, and women were offered VCV up to the time of amniocentesis. Infected fetuses were followed-up according to our clinical protocol.

Results

From February 2021 to August 2023, 2,777 first-trimester pregnant women between 8+0 and 13+6 gestational weeks were screened. Maternal IgG seroprevalence was 70.6%. Among these, 22 (0.8%) had IgM antibodies, four with low or intermediate avidity, suggesting a recent primary infection, and they received oral VCV 2 g/6 h. Vertical transmission occurred in one with a delayed start of VCV treatment and the family opted for termination of pregnancy.

Conclusions

Universal first-trimester CMV screening is feasible. A high seroprevalence was observed in our population. Larger studies will confirm whether screening is cost-effective in our setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsPregnancy Trimester, FirstPregnancy Complications, InfectiousCytomegalovirusHumansFemalePregnancyPilot ProjectsSpainAdultSeroepidemiologic StudiesTertiary Care CentersInfectious Disease Transmission, VerticalImmunoglobulin MYoung AdultAntibodies, Viral

Stichwörter der Autor:innen

CongenitalCytomegalovirusScreeningSeroprevalenceValacyclovir

Substanzen

Immunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • BCNatal Fetal Medicine Research Center, Hospital Clínic and Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain, karen.castillo.v@hotmail.com.
  • BCNatal Fetal Medicine Research Center, Hospital Clínic and Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • Department of Clinical Microbiology, Hospital Clinic, Institute for Global Health (ISGlobal), University of Barcelona, Barcelona, Spain.
  • Biochemistry and Molecular Genetics Laboratory, CDB, Hospital Clínic, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Zitieren

APA

Castillo, K. P., Guirado, L., Cahuana, A., Marcos, M. A., Mercadé, I., Casals Font, E., Liu, Q., Medina, C., López, M., Gómez-Roig, M. D., Figueras, F., & Goncé, A. (2025). First-Trimester Universal One-Time Serology Screening for Cytomegalovirus: A Pilot Study at Two Tertiary Referral Centers in Barcelona (Catalunya, Spain). Fetal Diagnosis and Therapy. https://doi.org/10.1159/000544169

Vancouver

Castillo KP, Guirado L, Cahuana A, Marcos MA, Mercadé I, Casals Font E, et al. First-Trimester Universal One-Time Serology Screening for Cytomegalovirus: A Pilot Study at Two Tertiary Referral Centers in Barcelona (Catalunya, Spain). Fetal Diagnosis and Therapy. 2025. doi:10.1159/000544169

BibTeX
@article{Castillo2025,
  author = {Castillo, Karen P and Guirado, Laura and Cahuana, Alex and Marcos, María Angeles and Mercadé, Imma and Casals Font, Elena and Liu, Qiqi and Medina, Clara and López, Marta and Gómez-Roig, María Dolores and Figueras, Francesc and Goncé, Anna},
  title = {First-Trimester Universal One-Time Serology Screening for Cytomegalovirus: A Pilot Study at Two Tertiary Referral Centers in Barcelona (Catalunya, Spain)},
  journal = {Fetal Diagnosis and Therapy},
  year = {2025},
  doi = {10.1159/000544169}
}
Kostenlos starten →